Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
EMAUF$0.27+0.01(+2.49%)Emperor Metals Inc. to Attend the 52nd Annual New Orleans Investment Conference[5:37:00 PM ET]TTMI$87.90+2.40(+2.81%)TTM Announces Completion of Existing 2025 Share Repurchase Program and Authorization of New $100 Million Program[5:36:20 PM ET]LXP$61.14+0.03(+0.05%)AvePoint Set to Join S&P SmallCap 600 AvePoint Inc. (NASD: AVPT) will replace LXP Industrial Trust (NYSE: LXP) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, ...[5:34:00 PM ET]FRFLF$0.010.00(0.00%)FRNT Financial Announces Adoption of Semi-Annual Reporting[5:30:00 PM ET]QGLDF$0.13+0.00(+0.91%)QGold Completes First Milestone Payment for Quartz Mountain Gold Project Through Share Issuance[5:30:00 PM ET]UTF$26.090.00(0.00%)Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a) This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources...[5:30:00 PM ET]RRGB$8.19-0.01(-0.12%)Red Robin Gourmet Burgers, Inc. Announces Board Changes Following Completion of Refinancing Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) ("Red Robin" or the "Company"), a casual dining restaurant chain serving an innovative selection of...[5:30:00 PM ET]KYIV$13.16+0.03(+0.23%)Kyivstar Group Signs Agreement to Acquire GigaCloud, Expanding Enterprise Cloud Capabilities[5:20:38 PM ET]MXCHF$1.34+0.14(+11.67%)Orbia Announces Third Quarter 2026 Financial Results[5:16:00 PM ET]GCRFF$0.450.00(0.00%)Airborne Magnetic Survey Generates 22 Priority Gold Exploration Targets[5:15:00 PM ET]NOA$12.30+0.42(+3.54%)North American Construction Group Ltd. Third Quarter Results Conference Call and Webcast Notification[5:15:00 PM ET]FE$46.27+0.09(+0.19%)FirstEnergy Foundation Strengthens Support for Shelter, Safety and Stability The FirstEnergy Foundation is investing $125,000 in seven West Virginia and Maryland organizations that provide emergency shelter, housing assistance ...[5:14:00 PM ET]FGBI$8.89+0.18(+2.07%)First Guaranty Bancshares Reports Third Quarter 2026 Results and Provides Strategic Update[5:10:08 PM ET]MAIN$54.04+0.70(+1.31%)Main Street Prices Public Offering of $500 Million of 6.55% Notes due 2030 Main Street Capital Corporation (NYSE: MAIN) ("Main Street") is pleased to announce that it has priced an underwritten public offering of $500...[5:05:00 PM ET]BX$116.84-2.22(-1.86%)Blackstone Prices $1.1 Billion Senior Notes Offering[5:01:00 PM ET]

CARL · NASDAQ

Carlsmed, Inc.

$15.41 +0.57 (+3.84%)

Company overview

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to leverage clinical intelligence, advanced image recognition, and 3D printing technologies. Its product, aprevo, is a medical platform that creates surgical plans and devices tailored to the precise medical situation of each individual patient. The company provides New Technology Add-On Payment (NTAP) reimbursement. Carlsmed was incorporated in 2018 and is based in Carlsbad, California.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Market cap
$421M
Employees
127
Headquarters
Carlsbad, CA
Website
carlsmed.com
CEO
Michael Cordonnier
Listed
July 23, 2025
P/E
-6.32
Dividend yield
0.00%

Company financials

Revenue
$56.4M
Gross profit
$42.8M
Operating income
-$21.8M
EBITDA
-$37.8M
Net income
-$33.2M
EPS
-$2.44
Total assets
$119M
Total debt
$17.3M
Gross margin
75.89%
Net margin
-58.80%
Earnings yield
-15.83%

Price chart

8.1510.5112.8715.2217.58
CARL 1D NASDAQ O14.63H15.49L14.51C14.91+0.38 (+2.62%)Vol123.74K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
CARLCarlsmed, Inc. Press release Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026 GlobeNewswire
CARLCarlsmed, Inc. Press release Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System GlobeNewswire
CARLCarlsmed, Inc. Press release Carlsmed, Inc. Announces Inducement Grants Under Nasdaq GlobeNewswire
CARLCarlsmed, Inc. Press release Carlsmed Appoints Tony Jarc as Chief Product and AI Officer GlobeNewsWire
CARLCarlsmed, Inc. Press release Carlsmed Appoints Richard Heppenstall as Chief Financial Officer GlobeNewsWire
CARLCarlsmed, Inc. Press release Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical GlobeNewsWire
CARLCarlsmed, Inc. Press release Carlsmed, Inc. Announces Chief Operating Officer Appointment GlobeNewsWire
CARLCarlsmed, Inc. Stock news Carlsmed, Inc. (CARL) Presents at Bank of America SMID Cap Virtual Conference Transcript Seeking Alpha
CARLCarlsmed, Inc. Stock news Carlsmed, Inc. (CARL) Q2 2026 Earnings Call Transcript Seeking Alpha
CARLCarlsmed, Inc. Stock news Carlsmed Q2 Earnings Call Highlights MarketBeat
CARLCarlsmed, Inc. Stock news Carlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue Estimates Zacks Investment Research
CARLCarlsmed, Inc. Press release Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance GlobeNewsWire
CARLCarlsmed, Inc. Press release Carlsmed, Inc. To Participate in Upcoming Investor Conferences GlobeNewsWire
CARLCarlsmed, Inc. Press release Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewsWire
CARLCarlsmed, Inc. Stock news Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High? Zacks Investment Research
CARLCarlsmed, Inc. Stock news Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript Seeking Alpha
CARLCarlsmed, Inc. Stock news Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet Zacks Investment Research
CARLCarlsmed, Inc. Stock news Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript Seeking Alpha
CARLCarlsmed, Inc. Stock news Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates Zacks Investment Research
CARLCarlsmed, Inc. Press release Carlsmed® Reports First Quarter 2026 Financial Results GlobeNewsWire
See more
FAQ

Questions about Carlsmed, Inc.

What does Carlsmed, Inc. do?
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to leverage clinical intelligence, advanced image recognition, and 3D printing technologies. Its product, aprevo, is a medical platform that creates surgical plans and devices tailored to the precise medical situation of each individual patient. The company provides New Technology Add-On Payment (NTAP) reimbursement. Carlsmed was incorporated in 2018 and is based in Carlsbad, California.
What is CARL's market cap?
Carlsmed, Inc. (CARL) is a listed stock with a live quote. The latest market cap on this page is $421M.
Where is Carlsmed, Inc. headquartered?
Carlsmed, Inc. is headquartered in Carlsbad, CA.
How do I get CARL news from the API?
Call GET /v1/news?tickers=CARL. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does CARL news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for CARL, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the CARL price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs